New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group-Reference-Cited by-同舟云学术

New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

Published:2024-04 Issue:4 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Bastos‐Oreiro Mariana¹^ORCID,Abrisqueta Pau²,Gutierrez Antonio³,Jiménez Ubieto Ana⁴,Poza Maria⁴,Fernanez‐Caldas Paula¹,LLacer María José¹,Gonzalez de Villambrosia Sonia⁵,Córdoba Raúl⁶,López Alberto⁶,Ceballos Elena⁷,Navarro Belen⁸,Muntañola Ana⁹,Donato Eva¹⁰,Diez‐Baeza Eva¹¹,Escoda Lourdes¹²,Luzardo Hugo¹³,Peñarrubia María José¹⁴,García Belmonte Daniel¹⁵,Pardal Emilia¹⁶,Lozada Claudia¹⁷,Martín García‐Sancho Alejandro¹¹

Affiliation:

1. Hospital Universitario Gregorio Marañon. Instituto de investigación Sanitaria Gregorio Marañon (IiSGM) Madrid Spain

2. Hospital Vall d Ebron Barcelona Spain

3. Hospital Son Espases IdISBa Palma de Mallorca Spain

4. Hospital Universitario 12 de Octubre Madrid Spain

5. Hospital Universitario de Valdecillas Santander Spain

6. Hospital Fundación Jimenez Díaz Madrid Spain

7. Hospital Morales Meseguer Murcia Spain

8. Hospital Universitario Puerta de Hierro Madrid Spain

9. Hospital Mutua Tarrasa Barcelona Spain

10. Hospital Dr Peset Valencia Spain

11. Hospital Universitario de Salamanca, IBSAL, CIBERONC Universidad de Salamanca Salamanca Spain